Clinical Trials › NCT05957913
Enrolling by InvitationPhase 2
Effects of Antiviral Therapies on Epstein-Barr Virus Replication
Sponsored by Massachusetts General Hospital
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 50
Target enrollment
1
U.S. states
Jun 2023
Start date
Dec 2026
Expected completion
Interventions / Treatments
Truvada (tenofovir/emtricitabine)
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Massachusetts1 site
Boston
Participating MS centers on MS Buddy (1)
Massachusetts General Hospital MS Clinic
Boston, MA
Boston, MA
MS centers in Massachusetts
Compare treatment centers near a trial site by center type, providers and trials.
View Massachusetts centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.